Phase 1 Study for IPG11406 in Health Volunteer

NCT06255834 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG: IPG11406

Sponsor

Nanjing Immunophage Biotech Co., Ltd

Collaborators

[object Object]